The Daily Bootie Newsletter for New Parents

New Parent Report Blog

Changing What They Watch on the Screen Can Improve Children’s Behavior

As most parents of preschoolers have witnessed, it’s common for children this age to imitate behaviors they see on television or in movies—whether violent, loving or something in between. This effect of media can be applied to positively impact children’s behavior, according to a study in the March 2013 issue of Pediatrics (published online Feb. 18).

For the study, “Modifying Media Content for Preschool Children: A Randomized Controlled Trial,” researchers studied 820 families with children aged 3 to 5 years who spent some time viewing screens each week. Through their community pediatric practices, half of the families participated in an intervention in which they replaced aggression-filled programming with “prosocial” and/or educational content for the children. The other half of the families were in the control group. The intervention did not attempt to reduce the number of hours of screen time for the children, but it did encourage a positive media diet and co-viewing with parents.

A case manager followed up with families regularly for 12 months. At 6 months and 12 months, the children in the intervention group were spending significantly less time on violent programming than they did at the start of the study compared to the control group. Both the intervention and control groups increased their viewing time slightly during the study, but the control group increased its minutes of violent content, while the intervention group increased its minutes of prosocial and educational content. At 6 months, the children in the intervention group demonstrated significantly less aggression and more prosocial behavior compared to the control group, and the effect lasted throughout the 12 months. The authors concluded that such an intervention can positively impact child behavior.

 

Courtesy of the American Academy of Pediatrics


Prenatal Folic Acid Supplementation Associated With Lower Risk of Autism

CHICAGO – In a study that included approximately 85,000 Norwegian children, maternal use of supplemental folic acid from 4 weeks before to 8 weeks after the start of pregnancy was associated with a lower risk of autistic disorder in children, according to a study appearing in the February 13 issue of JAMA.

“Supplementation with folic acid around the time of conception reduces the risk of neural tube defects in children. This protective effect has led to mandatory fortification of flour with folic acid in several countries, and it is generally recommended that women planning to become pregnant take a daily supplement of folic acid starting 1 month before conception,” according to background information in the article. It has not been determined whether prenatal folic acid supplements protect against other neurodevelopmental disorders.

Pal Surén, M.D., M.P.H., of the Norwegian Institute of Public Health, Oslo, and colleagues investigated the association between the use of maternal folic acid supplements before and in early pregnancy and the subsequent risk of autism spectrum disorders (ASDs) (autistic disorder, Asperger syndrome, pervasive developmental disorder-not otherwise specified [PDD-NOS]) in children. The study sample of 85,176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, 2012, the age range was 3.3 through 10.2 years (average age, 6.4 years). The exposure of primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Analyses were adjusted for maternal education level, year of birth, and parity (the number of live-born children a woman has delivered).

A total of 270 children (0.32 percent) in the study sample have been diagnosed with ASDs: 114 (0.13 percent) with autistic disorder, 56 (0.07 percent) with Asperger syndrome, and 100 (0.12 percent) with PDD-NOS. The researchers found that there was an inverse association between folic acid use and subsequent risk of autistic disorder. Autistic disorder was present in 0.10 percent (64/61,042) of children whose mothers took folic acid, compared with 0.21 percent (50/24,134) in children whose mothers did not take folic acid, representing a 39 percent lower odds of autistic disorder in children of folic acid users.

Characteristics of women who used folic acid within the exposure interval included being more likely to have college- or university-level education, to have planned the pregnancy, to be nonsmokers, to have a pre-pregnancy body mass index below 25, and to be first-time mothers.

“No association was found with Asperger syndrome or PDD-NOS, but power was limited. Similar analyses for prenatal fish oil supplements showed no such association with autistic disorder, even though fish oil use was associated with the same maternal characteristics as folic acid use,” the authors write.

The researchers note that the inverse association found for folic acid use in early pregnancy was absent for folic acid use in mid pregnancy.

“Our main finding was that maternal use of folic acid supplements around the time of conception was associated with a lower risk of autistic disorder. This finding does not establish a causal relation between folic acid use and autistic disorder but provides a rationale for replicating the analyses in other study samples and further investigating genetic factors and other biological mechanisms that may explain the inverse association,” the authors conclude.


Mutsy USA Recalls EVO Strollers Due to Strangulation Hazard

Evo Stroller (brown)

Name of product:

EVO strollers

Hazard:

The opening between the grab bar and seat bottom of the stroller can allow an infant’s body to pass through and become entrapped at the neck, posing a strangulation hazard to young children when a child is not harnessed.

Consumer Contact:

Contact Mutsy USA toll-free at (877) 546-9230 from 8 a.m. to 4 p.m. ET Monday through Friday, e-mail atusa@mutsy.nl, or visit the firm’s website at www.mutsy.com for recall information.

 

Recall Details

Units

About 340

Description

This recall includes EVO strollers manufactured between February 2012 (01.02.12) and November 2012 (30.11.12) with the following model numbers: MT12-03, MT12-11, MT12-14, MT12-31, MT12-34, MT12-37, MT12-39, MT12-42, MT12-43 and MT12-48. The model number and date code can be found underneath the stroller seat on a white sticker.  The strollers have black or silver-colored metal frames with brown, navy blue, black, or white seats.  “EVO” is printed on the lower back frame of the stroller.

Incidents/Injuries

None reported.

Remedy

Consumers should stop using the strollers immediately and contact Mutsy USA to receive a free replacement seat unit and grab bar.

Sold at

Juvenile product stores nationwide and websites including www.amazon.com between April 2012 and December 2012 for about $400.

Importer

Mutsy USA Inc., of Newark, N.J.

Manufacturer

Mutsy BV., of Goirle, Netherlands

Manufactured in

China

Courtesy of CPSC.gov


High blood pressure during pregnancy may signal later heart disease risk

High blood pressure during pregnancy — even once or twice during routine medical care — can signal substantially higher risks of heart and kidney disease and diabetes, according to new research in the American Heart Association journal Circulation.

“All of the later life risks were similar in pregnant women who could otherwise be considered low-risk — those who were young, normal weight, non-smokers, with no diabetes during pregnancy,” said Tuija Männistö, M.D., Ph.D., lead author of the study and a postdoctoral fellow at the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development in Rockville, Md.

Studies have shown higher heart and kidney disease risk in women with preeclampsia, a serious pregnancy-related disease marked with high blood pressure and measurable protein in the urine.

In the new study, researchers looked at less serious forms of high blood pressure that are much more common in pregnant women. For 40 years, they followed Finnish women who had babies in 1966. They calculated the risk of heart or kidney disease or diabetes in later life among women with high blood pressure during pregnancy, comparing them to women with normal blood pressure during pregnancy.

They found:

  • One-third of the women had at least one high blood pressure measurement during pregnancy.
  • Women who had any high blood pressure during pregnancy had 14 percent to over 100 percent higher risk of cardiovascular diseases later in life, compared to women with normal blood pressure during pregnancy.
  • Women who had any high blood pressure during pregnancy were 2 to 5 times more likely to die from heart attacks than women with normal blood pressure during pregnancy.
  • Women who had high blood pressure during pregnancy and healthy blood pressure levels after pregnancy had a 1.6- to 2.5-fold higher risk of having high blood pressure requiring medication or hospitalization later in life.
  • Women who had high blood pressure during pregnancy had a 1.4- to 2.2-fold higher risk of having diabetes in later life.
  • Women who had transient high blood pressure with and without measurable protein in the urine had a 1.9- to 2.8-fold higher risk of kidney disease in later life, compared to women with normal blood pressure during pregnancy. Transient high blood pressure is temporary high blood pressure that later returns to normal.

“According to our findings, women who have had high blood pressure during pregnancy or who are diagnosed with high blood pressure in pregnancy for the first time might benefit from comprehensive heart disease risk factor checks by their physicians, to decrease their long-term risk of heart diseases,” Männistö said.

Future research should estimate how lifestyle changes during pregnancy, such as diet, affect the risk of developing high blood pressure during pregnancy, Männistö said. Studies also should focus on how lifestyle changes and clinical follow-up after pregnancy could change these women’s long-term health.

Because the study was limited to non-Hispanic Caucasian Finnish women, researchers said they aren’t sure if results would be the same for other racial and ethnic groups.

The above story is reprinted from materials provided by American Heart Association.


Chickenpox Can Be Serious: Protect Your Child

Photo Credit: CDC

Most children with chickenpox completely recover. But it can be serious, even fatal, for babies, adolescents, and adults. Be proactive. Get vaccinated if you are not protected against chickenpox.

Chickenpox is a very contagious disease. You or your child may be at risk if you have never had chickenpox or have never gotten the vaccine. Chickenpox causes a blister-like rash, itching, tiredness, and fever. This can make you feel sick and very uncomfortable and cause you to miss 5 to 7 days of school or work.

First the Rash, Then the Blisters

Classic chickenpox symptoms are—

  • Red, itchy rash that usually starts on the face, chest, and back then spreads to the rest of the body
  • Fluid-filled blisters, resulting from the rash, that break and crust over

Most children with chickenpox completely recover in a week. But it can be severe for babies, adolescents, adults, pregnant women, and people with weakened immune systems.

Chickenpox used to be very common in this country. About 4 million people would get it each year. Also, 10,500 to 13,000 people were hospitalized and 100 to 150 people died because of chickenpox each year. Most people who had severe chickenpox were healthy beforehand. Read a mother’s story about her 13-month old child who had severe chickenpox .

Thankfully, chickenpox vaccine has changed all that.

Chickenpox Vaccine: Your Best Protection

Chickenpox vaccine is the best way to protect you and your child from chickenpox. Also, when you get vaccinated, you protect others in your community. This is especially important for people who cannot get vaccinated, such as those with weakened immune systems and pregnant women.

Children should get the first dose of chickenpox vaccine when they are 12 through 15 months old and the second dose at age 4 through 6 years. People 13 years of age and older who have never had chickenpox should get two doses at least 28 days apart. If you or your child only got one dose in the past, check with your doctor about getting a second dose.

Two doses of chickenpox vaccine are very effective at preventing severe disease, complications, and death. You can still get chickenpox if you have been vaccinated. But, it is usually milder with fewer blisters and little or no fever.

Some people should wait to get vaccinated or should not get vaccinated at all, including pregnant women and those with severe weakened immune systems. Learn more about who should not get chickenpox vaccine.

Chickenpox vaccine is safer than getting the disease. Make sure you and your children are protected.

Chickenpox Can Be Severe

Chickenpox can be severe for babies, adolescents, adults, pregnant women, and people with weakened immune systems. It can cause—

  • dehydration
  • pneumonia
  • bleeding problems
  • brain infection or inflammation
  • bacterial infections of the skin and soft tissues in children including Group A streptococcal infections
  • blood stream infections (sepsis)
  • toxic shock syndrome
  • bone infections
  • joint infections
  • death

If you have any questions about chickenpox or the vaccine, talk with your doctor.

Paying for Chickenpox Vaccine

Most health insurance plans cover the cost of vaccines. But, you may want to check with your insurance provider first. If you don’t have insurance, or if your plan does not cover vaccines, the Vaccines for Children Program may be able to help. This program helps children who are eligible get the vaccines they need. The vaccines are provided at no cost to doctors who serve children who are eligible.

Courtesy of CDC.gov


Million Dollar Baby Dressers Recalled by Bexco Due to Tip-Over Hazards; Two Toddler Deaths Reported

Units

18,000

Description

WASHINGTON, D.C. – The U.S. Consumer Product Safety Commission (CPSC), in cooperation with Bexco Enterprises Inc., dba Million Dollar Baby of Montebello, Calif. is announcing a voluntary recall of 18,000 children’s four-drawer dressers. When a young child climbs up on open dresser drawers, the dresser becomes unstable and poses the risk of tip over and entrapment. CPSC and Million Dollar Baby have received two reports of deaths associated with these dressers. An 11-month-old boy from Tulsa, Okla. and a 20-month-old girl from Camarillo, Calif. were reported to have suffocated when their dressers tipped over, entrapping them between the dresser and the floor. The cause of the deaths has not been determined.

This voluntary recall involves “Emily” style four-drawer dressers with model numbers M4712, M4722, M4732 and M4742 and similar “Ryan” dressers with the model M4733. The dressers were sold in five finishes: Cherry, Ebony, Espresso, Honey Oak and White. The model number, “Million Dollar Baby” and “MADE IN TAIWAN” are printed on a label located on the back of the dresser. The recalled dresser measures 33-inches high by 20-inches deep by 40-inches wide and is a part of the DaVinci children’s bedroom furniture collection. The dressers are made from pine and wood composite.

The recalled dressers were sold at JCPenney and independent juvenile specialty stores nationwide and online at Amazon.com, BabiesRUs.com, BabyUniverse.com and other online retailers from January 2006 through June 2010 for between $230 and $300.

The Million Dollar Baby dressers met applicable voluntary standards when first produced, but a May 2009 voluntary industry standard, and subsequent revisions published in October 2009 and November 2009, requires that tip-over restraints be sold with the dressers. The restraints attach to a wall, framing or other support to help prevent dresser tip-over entrapment hazards to young children. Million Dollar Baby is offering free retrofit kits with tip-over restraints to consumers who have older dressers. Included in the kit is an adhesive warning label that consumers are to attach to the dresser, which describes how to prevent tip-over injuries.

The dressers were manufactured in Taiwan and the USA.

Consumers should immediately stop using and keep the dresser out of a child’s reach. Consumers can contact Million Dollar Baby to receive a free retrofit kit that contains a wall anchor strap, which attaches to the dresser and wall to help prevent the dresser from tipping. The kits can be ordered by visiting the firm’s website atwww.themdbfamily.com/safety2 and click on Safety HQ or call toll-free at (888) 673-6652 between 8:30 a.m. and 5 p.m. PT Monday through Friday.

 

Courtesy of CPSC.gov


Triaminic and Theraflu Products Recalled Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

Units

About 2.3 Million

Description

This recall involves Triaminic® Syrups and Theraflu Warming Relief® Syrups for coughs, colds and fevers. There are 24 types of these two products included in the recall. A complete list of products, lot numbers and National Drug Codes (NDC) can be found at www.novartisOTC.com. Lot numbers are located on the bottom panel of the box and on the left side of the label on the bottle. The NDC number is located on the upper right corner of the front panel of the Triaminic Syrups box and the upper left corner of the Theraflu Warming Relief Syrups bottle.

Incidents/Injuries

The firm has received 12 reports of children unscrewing the locked caps, including four reports of children ingesting the product. One child required medical attention.

Remedy

Consumers should immediately stop using the recalled product and contact Novartis for instructions on how to return the product for a full refund.

Sold at

Food, drug, mass merchandise and club stores nationwide between May 2010 and December 2011 for about $5.

Manufacturer

Novartis Consumer Health Inc., of Parsippany, NJ

Manufactured in
U.S.A.

Courtesy of cpsc.gov.


It might not be the flu: RSV levels on the rise

Flu season is wreaking havoc around the country, and yet another seasonal illness, respiratory syncytial virus or RSV, appears to be peaking. In fact, according to CDC surveillance data, almost all states are reporting epidemic levels, including:
·         AZ – 25%
·         CA – 39%
·         FL – 12%
·         GA – 29%
·         IL – 23%
·         LA – 27%
·         NY – 15%
·         OH – 39%
·         TX – 29%
RSV is considered having reached epidemic levels once rates of positive cases are at or above 10% for two consecutive weeks.
What is RSV?
It’s a virus that’s often mistaken for a common cold, but this highly prevalent, easily-spread illness can be devastating and it’s affecting young infants across the country.  It’s called respiratory syncytial virus (RSV), and if contracted, it can bring serious complications to young infants, particularly to preemies whose underdeveloped lungs and immature immune systems make it harder to fight off the infection. In fact, RSV is the leading cause of infant hospitalization—about 125,000 each year—and is responsible for approximately 10 times more infant deaths each year than the flu.
According to the CDC, “RSV season” typically runs from November through March. All children can contract RSV, and nearly 100% of babies do by age two. Unfortunately, there is no cure for RSV, so prevention is key to protecting against this virus, which is highly contagious, particularly among children. For instance, daycare and pre-schools are common areas where children can contract RSV, but there are steps daycare providers and parents can take to help protect children.
Protecting your baby
Frequent washing of hands, toys, play areas and bedding is important, as RSV can live for several hours on surfaces such as countertops, doorknobs and tissues. Other preventative measures include keeping children away from those who are sick and never letting anyone smoke around the baby. Although RSV can be mild in many children, it’s best to air on the side of caution for the sake of other children. Parents of children who have cold-like symptoms should keep them home from daycare, to avoid exposing other children (especially those who may be at high-risk) from potentially dangerous germs.
Article courtesy of MedImmune.

Common anti-fever medications pose kidney injury risk for children

Sick children, especially those with some dehydration from flu or other illnesses, risk significant kidney injury if given drugs such as ibuprofen and naproxen, Indiana University School of Medicine researchers said Friday.

In an article published online Jan. 25 by the Journal of Pediatrics, Jason Misurac, M.D., and colleagues from IU and Butler University reported that nearly 3 percent of cases of pediatric acute kidney injury over a decade could be traced directly to having taken the common nonsteroidal anti-inflammatory drugs, or NSAIDs.

Although relatively few in terms of percentage of total kidney damage cases, the children with problems associated with NSAIDs included four young patients who needed dialysis, and at least seven who may have suffered permanent kidney damage, the researchers said.

“These cases, including some in which patients’ kidney function will need to be monitored for years, as well as the cost of treatment, are quite significant, especially when you consider that alternatives are available and acute kidney injury from NSAIDs is avoidable,” Dr. Misurac, a fellow in pediatric nephrology, said.

Although such drugs have been linked to kidney damage in small, anecdotal reports, the study reported Thursday is believed to be the first large-scale study of the incidence and impact of acute kidney injury caused by NSAIDs.

The research team evaluated medical records at Riley Hospital for Children at IU Health in Indianapolis from January 1999 through June 2010 and found 1,015 cases in which patients had been treated for acute kidney injury from any cause.

After excluding cases in which the acute kidney injuries could possibly be explained by other factors, such as diseases affecting kidney function, the researchers found 27 cases, or 2.7 percent, in which the only factors were the administration of NSAIDs. In nearly all cases, the NSAIDs were administered before the children were admitted to the hospital. Because many of the 1,015 cases involved multiple potential causes of acute kidney injury, the researchers said the 27 cases are likely an underestimate of the number of cases in which NSAIDs contributed to the kidney damage.

Among the researchers’ findings:

  • Most of the children had been treated with recommended dosages.
  • All of the children under the age of 5 needed to undergo dialysis temporarily, were more likely than the older children to be placed in an intensive care unit and needed longer hospital stays.
  • The average cost for hospital and kidney specialist fees in the 27 cases was nearly $13,500, and the costs were much higher for younger children. At least $375,000 was spent on the NSAID-associated kidney injury cases at Riley Hospital over the study period, the researchers said, but billing data for other specialists were not available in the database, suggesting that the actual costs were likely much higher.

 

NSAIDs affect kidney function by restricting blood flow to the blood-filtering components of the kidneys, which suggests the risks from the drugs are greater among children who are dehydrated due to the effects of their illness, such as vomiting or diarrhea, Dr. Misurac said.

Fever is normal during an infection and not in itself dangerous, he noted, so “one alternative to NSAIDs would be acetaminophen, but another alternative would be no medication at all, at least for a while, to let the body fight the infection.”

###

In addition to Dr. Misurac, authors of the paper are Sharon P. Andreoli, M.D., Jeffrey D. Leiser, M.D., Ph.D., Corina Nailescu, M.D., and Amy C. Wilson, M.D., of the IU School of Medicine, and Chad A. Knoderer, Pharm.D., of the Butler University College of Pharmacy and Health Sciences.

Courtesy of Eurekalert.org


Some With Autism Diagnosis Can Overcome Symptoms, Study Finds

Doctors have long believed that disabling autistic disorders last a lifetime, but a new study has found that some children who exhibit signature symptoms of the disorder recover completely.

The study, posted online on Wednesday by the Journal of Child Psychology and Psychiatry, is the largest to date of such extraordinary cases and is likely to alter the way that scientists and parents think and talk about autism, experts said.

Researchers on Wednesday cautioned against false hope. The findings suggest that the so-called autism spectrum contains a small but significant group who make big improvements in behavioral therapy for unknown, perhaps biological reasons, but that most children show much smaller gains. Doctors have no way to predict which children will do well.

Researchers have long known that between 1 and 20 percent of children given an autism diagnosis no longer qualify for one a few years or more later. They have suspected that in most cases the diagnosis was mistaken; the rate of autism diagnosis has ballooned over the past two decades, and some research suggests that it has been loosely applied.

The new study should put some of that skepticism to rest.

“This is the first solid science to address this question of possible recovery, and I think it has big implications,” said Sally Ozonoff of the MIND Institute at the University of California, Davis, who was not involved in the research. “I know many of us as would rather have had our tooth pulled than use the word ‘recover,’ it was so unscientific. Now we can use it, though I think we need to stress that it’s rare.”

She and other experts said the findings strongly supported the value of early diagnosis and treatment.

In the study, a team led by Deborah Fein of the University of Connecticut at Storrs recruited 34 people who had been diagnosed before the age of 5 and no longer had any symptoms. They ranged in age from 8 to 21 years old and early in their development were in the higher-than-average range of the autism spectrum. The team conducted extensive testing of its own, including interviews with parents in some cases, to gauge current social and communication skills.

The debate over whether recovery is possible has simmered for decades and peaked in 1987, when the pioneering autism researcher O. Ivar Lovaas reported that 47 percent of children with the diagnosis showed full recovery after undergoing a therapy he had devised. This therapy, a behavioral approach in which increments of learned skills garner small rewards, is the basis for the most effective approach used today; still, many were skeptical and questioned his definition of recovery.

Dr. Fein and her team used standardized, widely used measures and found no differences between the group of 34 formerly diagnosed people and a group of 34 matched control subjects who had never had a diagnosis.

“They no longer qualified for the diagnosis,” said Dr. Fein, whose co-authors include researchers from Queens University in Kingston, Ontario; Children’s Hospital of Philadelphia; the Institute of Living in Hartford; and the Child Mind Institute in New York. “I want to stress to parents that it’s a minority of kids who are able to do this, and no one should think they somehow missed the boat if they don’t get this outcome.”

On measures of social and communication skills, the recovered group scored significantly better than 44 peers who had a diagnosis of high-functioning autism or Asperger’s syndrome.

Dr. Fein emphasized the importance of behavioral therapy. “These people did not just grow out of their autism,” she said. “I have been treating children for 40 years and never seen improvements like this unless therapists and parents put in years of work.”

The team plans further research to learn more about those who are able to recover. No one knows which ingredients or therapies are most effective, if any, or if there are patterns of behavior or biological markers that predict such success.

“Some children who do well become quite independent as adults but have significant anxiety and depression and are sometimes suicidal,” said Dr. Fred Volkmar, the director of the Child Study Center at the Yale University School of Medicine. There are no studies of this group, he said.

That, because of the new study, is about to change.

 

Courtesy of The New York Times